Get the Stockscreener App
4.79
0.42%
-0.02
Champions Oncology Inc stock is traded at $4.79, with a volume of 9,913.
It is down -0.42% in the last 24 hours and up +0.42% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$4.81
Open:
$4.7999
24h Volume:
9,913
Relative Volume:
1.10
Market Cap:
$66.67M
Revenue:
$57.94M
Net Income/Loss:
$-2.34M
P/E Ratio:
-28.75
EPS:
-0.1666
Net Cash Flow:
$3.82M
1W Performance:
-3.82%
1M Performance:
+0.42%
6M Performance:
-22.49%
1Y Performance:
-27.20%
1-Day Range:
$4.7488
$4.855
1-Week Range:
$4.72
$4.99
52-Week Range:
$4.59
$8.3099
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
4.79 | 66.67M | 57.94M | -2.34M | 3.82M | -0.1666 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Champions Oncology Q3FY26 Results: Services revenue up 32% to $16.6m - scanx.trade
Champions Oncology Q4 2026 Earnings Call Transcript - Benzinga
Champions Oncology Q3 2026 Earnings Call Transcript - Benzinga
Full Transcript: Champions Oncology Q1 2027 Earnings Call - Benzinga
Champions Oncology Inc (2I3.MU) cash flow - Yahoo Finance Australia
Is Champions Oncology (NASDAQ:CSBR) Stock Worth Watching Today? - Kalkine Media
Full Transcript: Champions Oncology Q4 2026 Earnings Call - Benzinga
Champions Oncology Q4FY26 Results: Revenue up 12% to $59.4 million - scanx.trade
Champions Oncology, Inc.Common Stock (Nasdaq:CSBR) Price Chart - The Chronicle-Journal
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth - Eastern Progress
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth - The Globe and Mail
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth - Yahoo Finance
Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ... - finance.yahoo.com
Champions Oncology Narrows Q1 Loss to $426,000 - Minichart
CHAMPIONS ONCOLOGY, INC. 1Q 2027: Revenue $15.23M, EPS $(0.03) — 10-Q Summary - tradingview.com
CSBR 10-Q FilingsChampions Oncology, Inc. SEC 10-Q - stocktitan.net
Champions Oncology Q4 Results: Adjusted EPS beats estimates - scanx.trade
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript - The Globe and Mail
Champions Oncology, Inc. Q1 2027 Earnings Call Summary - finance.yahoo.com
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. - marketscreener.com
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript - The Globe and Mail
Champions Oncology Reports Revenue of $15.2 Million - Moomoo
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript - The Globe and Mail
CSBR|Champions Oncology Inc|Price:5.096|Chg%:+0.086 - TradingKey
Champions Oncology Fiscal Q1 2027 Earnings: Margin Expansion Lifts Adjusted EBITDA - TradingKey
Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com Nigeria
Champions Oncology Q1 Results: Adj. EPS up 400% to $0.05 - scanx.trade
Champions Oncology (CSBR) Q1 Fiscal 2027 Earnings Call: Revenue Up 9%, Services Margin Reaches 51% - TradingKey
Champions Oncology Q1 Earnings Call Highlights - finance.yahoo.com
Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com
Champions Oncology earnings beat by $0.06, revenue topped estimates - Investing.com
Champions Oncology reports Q1 revenue $15.2M, adjusted EBITDA $0.7M and oncology services margin 51% - tradingview.com
Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com India
CSBR: Revenue up 8.8% to $15.2M, oncology margin at 51%, adjusted EBITDA $671K, net loss $426K - TradingView
Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs - Investing.com
Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com UK
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026 - marketscreener.com
Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs - Investing.com UK
Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs - Investing.com
CHAMPIONS ONCOLOGY ($CSBR) Releases Q1 2027 Earnings - Quiver Quantitative
Champions Oncology Reports Revenue of $15.2 Million - accessnewswire.com
Champions Oncology Reports Revenue of $15.2 Million - New Castle News
Champions Oncology Reports Revenue of $15.2 Million - TradingView
CHAMPIONS ONCOLOGY ($CSBR) Releases Q1 2027 Earnings - Quiver Quantitative
Champions Oncology (CSBR) Earnings Date and Reports 2026 - MarketBeat
Champions Oncology Reports Revenue of $15.2 Million - Yahoo Finance
Champions Oncology Inc. (CSBR) Edges Higher as Shares Test $5.09Market Cap Weight - dars.gov.et
Oracle, Adobe, Copart and more set to report earnings Thursday By Investing.com - Investing.com Australia
Oracle, Adobe, Copart and more set to report earnings Thursday - Investing.com
CSBR Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):